[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1981

The Clinical Use of Clonidine in Abrupt Withdrawal From MethadoneEffects on Blood Prennssure and Specific Signs and Symptoms

Author Affiliations

From the Clinical Research Unit (Drs Charney, Sternberg, Heninger, and Redmond) and the Substance Abuse Treatment Unit (Dr Kleber), Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven.

Arch Gen Psychiatry. 1981;38(11):1273-1277. doi:10.1001/archpsyc.1981.01780360089010
Abstract

• Clonidine hydrochloride was found to be effective in the treatment of methadone hydrochloride withdrawal. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, 20 of 25 (80%) patients were able to withdraw completely from methadone by the end of a two-week period. In most patients, ten to 11 days of clonidine administration, with a peak mean dose of 16 μg/kg/day, resulted in a perceived reduction in symptoms compared with previous attempts to become opiate free. At these doses clonidine significantly reduced standing blood pressure without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, insomnia, and muscular aching were most resistant to clonidine treatment and were reported by the majority of patients.

×